Surgical Implications For LGBTQ Patients
AUAUniversity1 Heinä 2022

Surgical Implications For LGBTQ Patients

CME Available: https://auau.auanet.org/node/35725 Moderator: Jay D. Raman, MD, FACS Co-Hosts: Channa Amarasekera, MD; Simon Rosser, PhD, MPH LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify two specific surgical side effects that may be of interest to a patient who undergoes a prostatectomy (e.g. ED treatment efficacy for anal penetration, climacturia, anejaculation). 2. Ask relevant questions about sexual practices that may impact the side effects that are of interest to them (partner with men, women and both and anal receptive vs. anal penetration sex). ACKNOWLEDGEMENTS Support provided by independent educational grants from: Astellas AstraZeneca Bayer Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck & Co., Inc. Pfizer, Inc.

Jaksot(421)

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and ...

24 Loka 201854min

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

22 Loka 201817min

Incorporating New IO Therapies - Managing Patient Side Effects

Incorporating New IO Therapies - Managing Patient Side Effects

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

19 Loka 201830min

Immuno - Oncoloy: A New Class Of Drugs

Immuno - Oncoloy: A New Class Of Drugs

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal ...

10 Loka 201842min

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...

8 Loka 201856min

Incorporating New IO Therapies - Biomarkers

Incorporating New IO Therapies - Biomarkers

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

4 Loka 201829min

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a serie...

28 Syys 201851min

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

AUA2018 Take Home Messages - Infertility Andrology And Sexual Dysfunction

Take Home Messages from AUA2018 Infertility / Andrology Lawrence Jenkins, MD, MBA The Ohio State University Sexual Dysfunction Nelson Bennett, Jr., MD, FACS Northwestern University Feinberg School o...

26 Syys 201819min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-duodecim-lehti
jari-sarasvuo-podcast
psykologia
rss-koira-haudattuna
rahapuhetta
leveli
rss-uskonto-on-tylsaa
rss-valo-minussa-2
rss-luonnollinen-synnytys-podcast
rss-niinku-asia-on
kesken
salainen-paivakirja
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-tietoinen-yhteys-podcast-2